ported assessment of the secondary outcomes of interest: risk of haematoma, insertion site infection and limb ischaemia. Budz was the only study that assessed the presence of clots on the arterial catheter upon removal. Although five of the included studies monitored participant coagulation profiles throughout the trial-prothrombin time, partial thromboplastin time and platelet count-no comparative analysis on risk of bleeding was performed.